Journal article

THU165 PROPEL, PROPEL 2 And PROPEL OLE Studies Of Infigratinib In Children With Achondroplasia: Design And Status Of 3 Ongoing Trials

Ravi Savarirayan, Josep Maria De Bergua, Paul Arundel, Helen McDevitt, Valerie Cormier-Daire, Vrinda Saraff, Mars Skae, Borja Delgado, Antonio Leiva-Gea, Maria Salcedo, Jean-Pierre Salles, Marc P Nicolino, Massimiliano Rossi, Peter Kannu, Michael B Bober, John Phillips, Howard Saal, Paul Harmatz, Christine Burren, Toby Candler Show all

Journal of the Endocrine Society | The Endocrine Society | Published : 2023

DOI: 10.1210/jendso/bvad114.1416

Abstract

Abstract Disclosure: R. Savarirayan: Advisory Board Member; Self; Ascendis Pharma, BioMarin, QED Therapeutics, Sanofi. Consulting Fee; Self; BioMarin. Grant Recipient; Self; Ascendis Pharma, BioMarin, QED Therapeutics, Therachon. Research Investigator; Self; Ascendis Pharma, BioMarin, QED Therapeutics, Therachon. J. De Bergua: None. P. Arundel: None. H. McDevitt: None. V. Cormier-Daire: Advisory Board Member; Self; BioMarin. V. Saraff: None. M. Skae: None. B. Delgado: None. A. Leiva-Gea: None. M. Salcedo: None. J. Salles: None. M.P. Nicolino: None. M. Rossi: Advisory Board Member; Self; BioMarin. P. Kannu: Advisory Board Member; Self; Novartis, Ipsen. Grant Recipient; Self; CI..

View full abstract

University of Melbourne Researchers

Keywords

8 Decent Work and Economic Growth
Pediatric Research Initiative
3201 Cardiovascular Medicine and Haematology
Clinical Trials and Supportive Activities
Clinical Research
32 Biomedical and Clinical Sciences